Alpha DNA Investment Management’s iShares Core S&P 500 ETF IVV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,033
Closed -$425K 193
2023
Q1
$425K Buy
1,033
+10
+1% +$4.01K 0.13% 136
2022
Q4
$393K Buy
1,023
+18
+2% +$6.95K 0.14% 141
2022
Q3
$360K Sell
1,005
-695
-41% -$278K 0.3% 143
2022
Q2
$644K Buy
1,700
+52
+3% +$21.4K 0.55% 109
2022
Q1
$747K Buy
1,648
+412
+33% +$184K 0.52% 109
2021
Q4
$589K Buy
1,236
+49
+4% +$22.6K 0.37% 96
2021
Q3
$511K Hold
1,187
0.35% 99
2021
Q2
$510K Buy
1,187
+118
+11% +$49.4K 0.35% 98
2021
Q1
$425K Sell
1,069
-41
-4% -$15.9K 0.49% 97
2020
Q4
$416K Buy
+1,110
New +$395K 0.44% 96

Other funds holding IVV

Alpha DNA Investment Management's IVV Position: Q2 2023 in Review

Alpha DNA Investment Management sold out of iShares Core S&P 500 ETF (IVV) in Q2 2023, closing a stake of 1,033 shares — an estimated $425K sold.

Alpha DNA Investment Management first reported a position in IVV in Q4 2020 and held it in 10 quarters. The position peaked at $747K in Q1 2022. 2,719 funds tracked by Wall St. Rank hold IVV as of Q2 2023.

  • Alpha DNA Investment Management reported no remaining iShares Core S&P 500 ETF position as of Q2 2023 after selling out during the quarter.
  • Alpha DNA Investment Management sold 1,033 iShares Core S&P 500 ETF shares in Q2 2023, an estimated $425K.
  • Alpha DNA Investment Management first reported a position in iShares Core S&P 500 ETF in Q4 2020 and held it in 10 quarters.
  • Alpha DNA Investment Management's iShares Core S&P 500 ETF position peaked at $747K in Q1 2022.
  • 2,719 funds tracked by Wall St. Rank held iShares Core S&P 500 ETF as of Q2 2023.

Based on Alpha DNA Investment Management's 13F filing for Q2 2023, filed 31 Jul 2023.